ampelopsin has been researched along with Alzheimer Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Busquets, MA; Espargaró, A; Estelrich, J; Ginex, T; Luque, FJ; Muñoz-Torrero, D; Sabate, R; Vadell, MD | 1 |
| He, X; Li, Y; Liu, D; Liu, T; Lv, W; Wang, Y | 1 |
| Bi, J; Guo, L; Han, C; He, Z; Pei, H | 1 |
| Basu, S; Das, S; Majumder, T; Mukherjee, P; Sarkar, A | 1 |
| Chen, JF; Du, YH; Feng, J; He, GQ; Liu, Y; Liu, YJ; Wang, JX; Wang, KJ; Zhang, W; Zheng, M | 1 |
| Guo, J; Liu, LH; Qu, CH; Sun, P; Wang, CX; Wang, SH; Yin, JB | 1 |
| Liang, J; Lindemeyer, AK; López-Valdés, HE; Martínez-Coria, H; Olsen, RW; Shao, XM; Shen, Y | 1 |
8 other study(ies) available for ampelopsin and Alzheimer Disease
| Article | Year |
|---|---|
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apigenin; Benzaldehydes; Cinnamates; Depsides; Flavonoids; Humans; In Vitro Techniques; Molecular Structure; Peptide Fragments; Phenols; Quercetin; Rosmarinic Acid | 2017 |
Ampelopsin Improves Cognitive Impairment in Alzheimer's Disease and Effects of Inflammatory Cytokines and Oxidative Stress in the Hippocampus.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alzheimer Disease; Animals; Cognitive Dysfunction; Cytokines; Dinoprost; Disease Models, Animal; Flavonoids; Hippocampus; Inflammation; Male; Maze Learning; Memory, Short-Term; Neuroprotective Agents; Oxidative Stress; Rats | 2020 |
Dihydromyricetin suppresses inflammatory injury in microglial cells to improve neurological behaviors of Alzheimer's disease mice via the TLR4/MD2 signal.
Topics: Alzheimer Disease; Animals; Flavonols; Mice; Mice, Inbred C57BL; Microglia; Toll-Like Receptor 4 | 2023 |
Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Disaccharides; Flavonoids; Flavonols; Humans; Molecular Docking Simulation; Neurons; Oxidative Stress; Plaque, Amyloid; Protein Conformation; Quantitative Structure-Activity Relationship; Quercetin | 2020 |
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Brain; Cell Line, Transformed; Cognition Disorders; Cytokines; Disease Models, Animal; Encephalitis; Flavonols; Gene Expression Regulation; Humans; Inflammasomes; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mutation; NLR Family, Pyrin Domain-Containing 3 Protein; Presenilin-1; RNA, Messenger; Time Factors | 2018 |
Protective role of Dihydromyricetin in Alzheimer's disease rat model associated with activating AMPK/SIRT1 signaling pathway.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Animals; Apoptosis; Cognition; Cytokines; Disease Models, Animal; Flavonols; Gene Expression Regulation; Hippocampus; Injections, Intraperitoneal; Injections, Intraventricular; Male; Maze Learning; Memory; Neurons; Nootropic Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1; Stereotaxic Techniques | 2019 |
Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anxiety; Cognition Disorders; Disease Models, Animal; Flavonols; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2014 |